The sensitivity of cancer cells to VSV and OVs in general (compared to the healthy cells) is mainly attributed to the low expression levels of type I IFNs (IFNα and IFNβ) and overall to the various defects in receptors and the active members of type I IFN signaling. The gene discussed is IFNA1; the disease is cancer.